Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 412

1.

Poor Outcome of Experimental Ischemic Stroke in Type 2 Diabetic Rats: Impaired Circulating Endothelial Progenitor Cells Mobilization.

Yang H, Ma S, Liu Y, Li Y, Wu W, Han E, Jia G, Wang C.

J Stroke Cerebrovasc Dis. 2015 Mar 23. pii: S1052-3057(14)00635-1. doi: 10.1016/j.jstrokecerebrovasdis.2014.12.022. [Epub ahead of print]

PMID:
25813059
2.

Diabetes Mellitus and Blood-Brain Barrier Dysfunction: An Overview.

Prasad S, Sajja RK, Naik P, Cucullo L.

J Pharmacovigil. 2014 Jun;2(2):125.

3.

[Multiple risk factors models of patients with acute coronary syndromes of different genders].

Sun W, Hu T, Huang X, Zhang Y, Guo J, Wang W, Shi F, Wang P, Wang H, Sun J, Li C.

Zhonghua Yi Xue Za Zhi. 2014 Dec;94(47):3735-9. Chinese.

PMID:
25623096
4.

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial.

Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM; SAVOR-TIMI 53 Steering Committee and Investigators.

Diabetes Care. 2015 Apr;38(4):696-705. doi: 10.2337/dc14-1850. Epub 2014 Dec 31.

PMID:
25552421
5.

Health outcomes of vitamin D. Part II. Role in prevention of diseases.

Wranicz J, Szostak-Węgierek D.

Rocz Panstw Zakl Hig. 2014;65(4):273-9.

6.

Persistent cerebrovascular damage after stroke in type two diabetic rats measured by magnetic resonance imaging.

Ding G, Yan T, Chen J, Chopp M, Li L, Li Q, Cui C, Ning R, Jiang Q.

Stroke. 2015 Feb;46(2):507-12. doi: 10.1161/STROKEAHA.114.007538. Epub 2014 Dec 18.

PMID:
25523056
7.

Type 2 diabetes is associated with a worse functional outcome of ischemic stroke.

Tziomalos K, Spanou M, Bouziana SD, Papadopoulou M, Giampatzis V, Kostaki S, Dourliou V, Tsopozidi M, Savopoulos C, Hatzitolios AI.

World J Diabetes. 2014 Dec 15;5(6):939-44. doi: 10.4239/wjd.v5.i6.939.

8.

Body mass index and stroke risk among patients with type 2 diabetes mellitus.

Li W, Katzmarzyk PT, Horswell R, Zhang Y, Zhao W, Wang Y, Johnson J, Hu G.

Stroke. 2015 Jan;46(1):164-9. doi: 10.1161/STROKEAHA.114.006718. Epub 2014 Dec 2.

PMID:
25468880
9.

Risk of cardiovascular disease: the effects of diabetes and anti-diabetic drugs - a nested case-control study.

Gejl M, Starup-Linde J, Scheel-Thomsen J, Gregersen S, Vestergaard P.

Int J Cardiol. 2015 Jan 15;178:292-6. doi: 10.1016/j.ijcard.2014.11.096. Epub 2014 Nov 12.

PMID:
25465309
10.

Health care costs attributable to overweight calculated in a standardized way for three European countries.

Lette M, Bemelmans WJ, Breda J, Slobbe LC, Dias J, Boshuizen HC.

Eur J Health Econ. 2014 Nov 29. [Epub ahead of print]

PMID:
25432787
11.

Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.

Kim SC, Glynn RJ, Liu J, Everett BM, Goldfine AB.

Acta Diabetol. 2014 Dec;51(6):1015-23. doi: 10.1007/s00592-014-0663-2. Epub 2014 Oct 14.

PMID:
25311055
12.
13.

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.

Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL; SAVOR-TIMI 53 Steering Committee and Investigators*.

Circulation. 2014 Oct 28;130(18):1579-88. doi: 10.1161/CIRCULATIONAHA.114.010389. Epub 2014 Sep 4.

PMID:
25189213
14.

Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.

Chehaibi K, Nouira S, Mahdouani K, Hamdi S, Rouis M, Slimane MN.

J Mol Neurosci. 2014 Dec;54(4):730-8. doi: 10.1007/s12031-014-0326-3. Epub 2014 May 21.

PMID:
24841086
15.

Matrix metalloproteinase-1 and matrix metalloproteinase-12 gene polymorphisms and the risk of ischemic stroke in a Tunisian population.

Chehaibi K, Hrira MY, Nouira S, Maatouk F, Ben Hamda K, Slimane MN.

J Neurol Sci. 2014 Jul 15;342(1-2):107-13. doi: 10.1016/j.jns.2014.04.036. Epub 2014 May 2.

PMID:
24834994
16.

[Alcohol drinking and peripheral arterial disease of lower extremity].

Wakabayashi I, Sotoda Y.

Nihon Arukoru Yakubutsu Igakkai Zasshi. 2014 Feb;49(1):13-27. Review. Japanese.

PMID:
24818355
17.

Antidiabetic treatment, stroke severity and outcome.

Magkou D, Tziomalos K.

World J Diabetes. 2014 Apr 15;5(2):84-8. doi: 10.4239/wjd.v5.i2.84. Review.

18.

Occurrence and predictors of persistent impaired glucose tolerance after acute ischemic stroke or transient ischemic attack.

Fonville S, den Hertog HM, Zandbergen AA, Koudstaal PJ, Lingsma HF.

J Stroke Cerebrovasc Dis. 2014 Jul;23(6):1669-75. doi: 10.1016/j.jstrokecerebrovasdis.2014.01.012. Epub 2014 Apr 13.

PMID:
24725814
19.

Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases.

Pretorius E, Kell DB.

Integr Biol (Camb). 2014 May;6(5):486-510. doi: 10.1039/c4ib00025k. Review.

PMID:
24714688
20.

Increased risk of ischemic stroke after hyperosmolar hyperglycemic state: a population-based follow-up study.

Wang JY, Wang CY, Huang YS, Chen PF, Huang KY, Chou P, Lian WC, Lee CC.

PLoS One. 2014 Apr 8;9(4):e94155. doi: 10.1371/journal.pone.0094155. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk